Year of Diagnosis |
Total | In Situ | Localized | Regional | Distant | Unknown | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
Number | Percent | Number | Percent | Number | Percent | Number | Percent | Number | Percent | ||
2016-2020 | 584 | 112 | 19.2 | 324 | 55.5 | 124 | 21.2 | 16 | 2.7 | 8 | 1.4 |
2015-2019 | 526 | 102 | 19.4 | 285 | 54.2 | 112 | 21.3 | 15 | 2.9 | 12 | 2.3 |
2014-2018 | 509 | 104 | 20.4 | 277 | 54.4 | 100 | 19.6 | 14 | 2.8 | 14 | 2.8 |
2013-2017 | 502 | 115 | 22.9 | 261 | 52.0 | 98 | 19.5 | 13 | 2.6 | 15 | 3.0 |
2012-2016 | 499 | 120 | 24.0 | 251 | 50.3 | 94 | 18.8 | 17 | 3.4 | 17 | 3.4 |
2011-2015 | 481 | 120 | 24.9 | 256 | 53.2 | 73 | 15.2 | 15 | 3.1 | 17 | 3.5 |
2010-2014 | 479 | 123 | 25.7 | 250 | 52.2 | 74 | 15.4 | 16 | 3.3 | 16 | 3.3 |
2009-2013 | 482 | 114 | 23.7 | 258 | 53.5 | 80 | 16.6 | 15 | 3.1 | 15 | 3.1 |
2008-2012 | 466 | 103 | 22.1 | 251 | 53.9 | 85 | 18.2 | 13 | 2.8 | 14 | 3.0 |
2007-2011 | 445 | 93 | 20.9 | 231 | 51.9 | 99 | 22.2 | 8 | 1.8 | 14 | 3.1 |
2006-2010 | 426 | 83 | 19.5 | 221 | 51.9 | 102 | 23.9 | 7 | 1.6 | 13 | 3.1 |
2005-2009 | 445 | 84 | 18.9 | 232 | 52.1 | 105 | 23.6 | 11 | 2.5 | 13 | 2.9 |
2004-2008 | 419 | 81 | 19.3 | 200 | 47.7 | 108 | 25.8 | 10 | 2.4 | 20 | 4.8 |
2003-2007 | 387 | 73 | 18.9 | 182 | 47.0 | 103 | 26.6 | 10 | 2.6 | 19 | 4.9 |
2002-2006 | 380 | 71 | 18.7 | 190 | 50.0 | 89 | 23.4 | 9 | 2.4 | 21 | 5.5 |
2001-2005 | 356 | 67 | 18.8 | 167 | 46.9 | 83 | 23.3 | 9 | 2.5 | 30 | 8.4 |
2000-2004 | 324 | 55 | 17.0 | 152 | 46.9 | 82 | 25.3 | 3 | 0.9 | 32 | 9.9 |
1999-2003 | 333 | 52 | 15.6 | 174 | 52.3 | 73 | 21.9 | 4 | 1.2 | 30 | 9.0 |
1998-2002 | 317 | 51 | 16.1 | 152 | 47.9 | 64 | 20.2 | 8 | 2.5 | 42 | 13.2 |
1997-2001 | 312 | 52 | 16.7 | 138 | 44.2 | 65 | 20.8 | 11 | 3.5 | 46 | 14.7 |
1996-2000 | 304 | 46 | 15.1 | 135 | 44.4 | 63 | 20.7 | 13 | 4.3 | 47 | 15.5 |
1995-1999 | 333 | 43 | 12.9 | 151 | 45.3 | 67 | 20.1 | 16 | 4.8 | 56 | 16.8 |
1994-1998 | 316 | 41 | 13.0 | 133 | 42.1 | 69 | 21.8 | 16 | 5.1 | 57 | 18.0 |
1993-1997 | 312 | 37 | 11.9 | 138 | 44.2 | 66 | 21.2 | 12 | 3.8 | 59 | 18.9 |
1992-1996 | 305 | 29 | 9.5 | 143 | 46.9 | 63 | 20.7 | 9 | 3.0 | 61 | 20.0 |
1991-1995 | 307 | 30 | 9.8 | 145 | 47.2 | 63 | 20.5 | 10 | 3.3 | 59 | 19.2 |
1990-1994 | 271 | 26 | 9.6 | 130 | 48.0 | 55 | 20.3 | 7 | 2.6 | 53 | 19.6 |
1989-1993 | 263 | 24 | 9.1 | 123 | 46.8 | 49 | 18.6 | 7 | 2.7 | 60 | 22.8 |
1988-1992 | 257 | 25 | 9.7 | 122 | 47.5 | 47 | 18.3 | 7 | 2.7 | 56 | 21.8 |
1987-1991 | 242 | 19 | 7.9 | 109 | 45.0 | 38 | 15.7 | 9 | 3.7 | 67 | 27.7 |
1986-1990 | 224 | 18 | 8.0 | 93 | 41.5 | 36 | 16.1 | 5 | 2.2 | 72 | 32.1 |
1985-1989 | 222 | 19 | 8.6 | 86 | 38.7 | 31 | 14.0 | 9 | 4.1 | 77 | 34.7 |
Notes: |
---|
In Situ Stage represents the presence of malignant cells within the cell group from which they arose, with no penetration of basement membrane of the tissue and no stromal invasion. |
Localized Stage represents invasive cancer confined to the organ of origin or intralumenal extension where specified as an intralumenal extension to immediately contiguous segments of the large bowel. |
Regional Stage represents direct extension to adjacent organs or tissues or involvement of the regional lymph nodes. |
Distant Stage represents direct continuity to non-adjacent organs, discontinuous metastasis or involvement of the distant lymph nodes. |
COVID-19 Pandemic: In 2020, the highly publicized impact of the COVID-19 pandemic on health services and the consequential delays and reductions in cancer screening and diagnosis led to a decline in the 2020 incidence rates for most cancer sites. Because 2020 was a temporary, anomalous year, it can bias estimates such as cancer incidence trends. |
Source : Michigan Resident Cancer Incidence File. Updated with cases processed through November 30, 2022. Division for Vital Records & Health Statistics, Michigan Department of Health & Human Services. |
Last Updated : April 13, 2023 |